146 Bull. Chem. Soc. Jpn. Vol. 81, No. 1 (2008)
Copper-Catalyzed [2,3]Sigmatropic Rearrangement
hexenoate (3d): Each of rearrangement products were separated
carefully from E/Z mixture to give 13% of Z-3d and 32% of E-3d.
E-3d: IR (neat): 2980, 2932, 2865, 2834, 2790, 1718, 1494, 1447,
1384, 1365, 1204, 1092, 1068, 1028, 739, 701. 1H NMR (400
MHz, CDCl3): ꢁ 1.21 (s, 3H), 1.33 (t, J ¼ 7:1 Hz, 3H), 2.30 (s,
6H), 2.49 (d, J ¼ 13:2 Hz, 1H), 3.07 (d, J ¼ 13:2 Hz, 1H), 3.81 (d,
J ¼ 6:3 Hz, 2H), 4.27–4.32 (m, 4H), 5.12 (t, J ¼ 6:3 Hz, 1H),
7.08–7.36 (m, 10H). 13C NMR (100 MHz, CDCl3): ꢁ 14.8, 17.8,
40.4, 47.4, 60.2, 66.4, 71.5, 74.3, 126.3, 126.7, 127.1, 127.3,
127.6, 128.0, 128.2, 128.3, 129.6, 136.0, 138.5, 169.7. Anal. Calcd
for C24H31NO3: C, 75.56; H, 8.19; N, 3.67%. Found: C, 75.54; H,
8.28; N, 3.38%.
syringe pump, the reaction mixture was stirred for 20 min–18 h
listed in the table. When the reaction mixture was cooled, diethyl
ether was added, and the suspension was filtered. The solvent
was then removed in vacuo, and the residue was purified by
column chromatography on silica gel with hexane/EtOAc (3:1)
to give corresponding homoallylamines as pale yellow oil. The
yield was calculated on the basis of the amount of the diazo
compounds.
Ethyl 4-Chloro-2-(dimethylamino)-4-pentenoate (3i):
(neat): 2980, 2940, 2871, 2834, 2789, 1731, 1637, 1455, 1371,
1246, 1228, 1175, 1098, 1035, 886, 637 cmꢂ1 1H NMR (400
IR
.
MHz, CDCl3): ꢁ 1.29 (t, J ¼ 7:1 Hz, 3H), 2.37 (s, 6H), 2.65 (ddd,
J ¼ 0:7, 6.8, 14.4 Hz, 1H), 2.78 (ddd, J ¼ 0:7, 7.8, 14.4 Hz, 1H),
3.59 (dd, J ¼ 6:8, 7.8 Hz, 1H), 4.19 (dq, J ¼ 2:4, 7.1 Hz, 2H),
5.22 (d, J ¼ 1:2 Hz, 1H), 5.24 (d, J ¼ 1:2 Hz, 1H). 13C NMR
(100 MHz, CDCl3): ꢁ 14.4, 39.0, 41.5, 60.3, 64.8, 114.7, 139.0,
170.7. Anal. Calcd for C9H16ClNO2: C, 52.56; H, 7.84; N, 6.81%.
Found: C, 52.48; H, 7.80; N, 6.62%.
Ethyl 10-Benzyloxy-4,8-dimethyl-2-(dimethylamino)-2-phen-
yl-4,8-decadienoate (E-3e): IR (neat): 2978, 2937, 2866, 2790,
.
1719, 1446, 1120, 1094, 1067, 1027, 737, 701 cmꢂ1 1H NMR
(400 MHz, CDCl3): ꢁ 1.18 (s, 3H), 1.32 (t, J ¼ 6:9 Hz, 3H), 1.57
(s, 3H), 1.80–1.89 (m, 4H), 2.29 (s, 6H), 2.36 (d, J ¼ 13:2 Hz,
1H), 3.02 (d, J ¼ 13:2 Hz, 1H), 4.00 (d, J ¼ 6:6 Hz, 2H), 4.28
(q, J ¼ 6:9 Hz, 2H), 4.49 (s, 2H), 4.80 (t, J ¼ 6:6 Hz, 1H), 5.31
(t, J ¼ 6:6 Hz, 1H), 7.12–7.35 (m, 10H). 13C NMR (100 MHz,
CDCl3): ꢁ 14.9, 16.6, 17.4, 26.4, 39.1, 40.5, 47.5, 60.1, 66.6, 72.0,
74.4, 120.4, 126.5, 126.9, 127.3, 127.7, 128.2, 128.3, 129.0, 131.1,
138.3, 139.6, 140.2, 169.6. Anal. Calcd for C29H39NO3: C, 77.47;
H, 8.74; N, 3.12%. Found: C, 77.30; H, 8.87; N, 2.91%.
Diethyl 2-Dimethylamino-4-methyleneglutarate (3j):
(neat): 2980, 2938, 2871, 2833, 2788, 1728, 1632, 1448, 1370,
1298, 1266, 1243, 1185, 1097, 1033, 937, 817 cmꢂ1 1H NMR
IR
.
(400 MHz, CDCl3): ꢁ 1.27 (t, J ¼ 7:1 Hz, 3H), 1.31 (t, J ¼ 7:1 Hz,
3H), 2.35 (s, 6H), 2.64–2.74 (m, 2H), 3.45 (dd, J ¼ 6:7, 8.5 Hz,
1H), 4.15 (dq, J ¼ 2:1, 7.1 Hz, 2H), 4.22 (q, J ¼ 7:1 Hz, 2H), 5.61
(d, J ¼ 1:3 Hz, 1H), 6.20 (d, J ¼ 1:3 Hz, 1H). 13C NMR (100
MHz, CDCl3): ꢁ 14.2, 14.4, 31.9, 41.7, 60.2, 60.7, 66.3, 127.1,
137.1, 166.7, 171.4. Anal. Calcd for C12H21NO4: C, 59.24; H,
8.70; N, 5.76%. Found: C, 59.04; H, 8.73; N, 5.71%.
Ethyl 4-Cyano-2-(dimethylamino)-4-pentenoate (3k): IR
(neat): 2981, 2941, 2871, 2836, 2790, 2224, 1729, 1624, 1454,
1370, 1236, 1178, 1097, 1034 cmꢂ1. 1H NMR (400 MHz, CDCl3):
ꢁ 1.30 (t, J ¼ 7:1 Hz, 3H), 2.36 (s, 6H), 2.55–2.68 (m, 2H), 3.49
(dd, J ¼ 7:3, 8.3 Hz, 1H), 4.14–4.26 (m, 2H), 5.80 (d, J ¼ 0:5 Hz,
1H), 5.92 (d, J ¼ 0:5 Hz, 1H). 13C NMR (100 MHz, CDCl3): ꢁ
14.5, 34.3, 41.4, 60.5, 65.2, 118.1, 119.9, 132.3, 170.2. Anal.
Calcd for C10H16N2O2: C, 61.20; H, 8.22; N, 14.27%. Found:
C, 60.97; H, 8.29; N, 14.02%.
Ethyl 4-Cyano-2-(dimethylamino)-2-phenyl-4-pentenoate
(3l): IR (neat): 2983, 2940, 2836, 2793, 2223, 1721, 1493, 1447,
1297, 1227, 1192, 1068, 1027, 946, 705 cmꢂ1 1H NMR (400
.
MHz, CDCl3): ꢁ 1.35 (t, J ¼ 7:1 Hz, 3H), 2.38 (s, 6H), 2.91 (dabq,
J ¼ 1:0, 14.0, 28.0 Hz, 2H), 4.34 (q, J ¼ 7:1 Hz, 2H), 5.10 (d,
J ¼ 1:0 Hz, 1H), 5.68 (d, J ¼ 1:0 Hz, 1H), 7.24–7.32 (m, 5H).
13C NMR (100 MHz, CDCl3): ꢁ 14.8, 40.7, 42.9, 60.8, 74.1, 118.4,
118.6, 127.5, 127.6, 128.1, 135.4, 138.5, 159.5. Anal. Calcd for
C16H20N2O2: C, 70.56; H, 7.40; N, 10.29%. Found: C, 70.33;
H, 7.51; N, 10.00%.
Ethyl 2-Acetyl-6-benzyloxy-2-(dimethylamino)-4-methyl-4-
hexenoate (E-3f): IR (neat): 2930, 2856, 2792, 1717, 1454,
.
1352, 1206, 1072, 1027, 740, 699 cmꢂ1 1H NMR (400 MHz,
CDCl3): ꢁ 1.30 (t, J ¼ 7:1 Hz, 3H), 1.61 (s, 3H), 2.18 (s, 3H), 2.33
(s, 6H), 2.76 (abq, J ¼ 13:9, 76.1 Hz, 2H), 3.97 (d, J ¼ 6:6 Hz,
2H), 4.24 (q, J ¼ 7:1 Hz, 2H), 4.46 (s, 2H), 5.46 (dt, J ¼ 1:0,
6.6 Hz, 1H), 7.25–7.35 (m, 5H). 13C NMR (100 MHz, CDCl3): ꢁ
14.5, 17.0, 28.0, 40.8, 43.1, 60.8, 66.2, 72.0, 79.7, 126.2, 127.4,
127.7, 128.2, 135.6, 138.3, 168.2, 204.1. Anal. Calcd for C20H29-
NO4: C, 69.14; H, 8.41; N, 4.03%. Found: C, 69.12; H, 8.47; N,
3.82%.
Diethyl 2-(4-Benzyloxy-2-methyl-2-butenyl)-2-(dimethyl-
amino)malonate (E-3g): IR (neat): 2981, 2956, 2905, 2871,
2792, 1754, 1726, 1454, 1227, 1072, 1027, 741, 699 cmꢂ1
.
1H NMR (400 MHz, CDCl3): ꢁ 1.27 (t, J ¼ 7:1 Hz, 6H), 1.68 (s,
3H), 2.38 (s, 6H), 2.82 (s, 2H), 4.00 (d, J ¼ 6:6 Hz, 2H), 4.21 (q,
J ¼ 7:1 Hz, 4H), 4.46 (s, 2H), 5.52 (t, J ¼ 6:6 Hz, 1H), 7.27–7.35
(m, 5H). 13C NMR (100 MHz, CDCl3): ꢁ 14.4, 17.3, 40.8, 43.7,
61.0, 66.3, 71.9, 75.5, 125.6, 127.3, 127.6, 128.1, 135.5, 138.3,
167.9. Anal. Calcd for C21H31NO5: C, 66.82; H, 8.28; N, 3.71%.
Found: C, 66.90; H, 8.34; N, 3.57%.
Diethyl 2-(8-Benzyloxy-2,6-dimethyl-2,6-octadienyl)-2-(di-
methylamino)malonate (E-3h): IR (neat): 2980, 2936, 2857,
2790, 1755, 1726, 1454, 1226, 1098, 1068, 1029, 740, 699 cmꢂ1
.
Ethyl
(3m): IR (neat): 2985, 2843, 2796, 2224, 1718, 1617, 1462,
2-Acetyl-4-cyano-2-(dimethylamino)-4-pentenoate
1H NMR (400 MHz, CDCl3): ꢁ 1.23 (t, J ¼ 7:1 Hz, 6H), 1.63 (s,
6H), 1.99–2.11 (m, 4H), 2.36 (s, 6H), 2.75 (s, 2H), 4.02 (d, J ¼
6:7 Hz, 2H), 4.20 (q, J ¼ 7:1 Hz, 4H), 4.50 (s, 2H), 5.25 (t, J ¼
6:7 Hz, 1H), 5.39 (dt, J ¼ 1:0, 6.7 Hz, 1H), 7.25–7.37 (m, 5H).
13C NMR (100 MHz, CDCl3): ꢁ 14.5, 16.6, 16.8, 26.5, 39.4,
40.8, 43.9, 60.8, 66.6, 72.0, 75.7, 120.8, 127.3, 127.6, 128.2,
128.5, 131.0, 138.4, 139.9, 168.0. Anal. Calcd for C26H39NO5:
C, 70.08; H, 8.82; N, 3.14%. Found: C, 69.90; H, 8.87; N, 3.02%.
General Procedure for the Copper-Catalyzed [2,3]Sigma-
tropic Rearrangements (Table 3). Unless otherwise noted, the
reaction was performed with Cu(acac)2 (0.1 mmol) and allylamine
(3 mmol) in the solvents (7 mL) listed in the table and diazo com-
pound (1 mmol) in the appropriate solvent (2 mL) under an atmo-
sphere of argon. After the addition of the diazo compound using a
1
1356, 1233, 1168, 1050, 952 cmꢂ1. H NMR (400 MHz, CDCl3):
ꢁ 1.33 (t, J ¼ 7:1 Hz, 3H), 2.24 (s, 3H), 2.41 (s, 6H), 2.90 (dabq,
J ¼ 1:1, 14.9, 24.4 Hz, 2H), 4.29 (dq, J ¼ 1:2, 7.1 Hz, 2H), 5.85
(s, 1H), 5.99 (s, 1H). 13C NMR (100 MHz, CDCl3): ꢁ 14.3, 27.9,
36.4, 40.8, 61.6, 79.4, 117.9, 118.2, 135.5, 167.9, 203.3. Anal.
Calcd for C12H18N2O3: C, 60.49; H, 7.61; N, 11.76%. Found: C,
60.38; H, 7.65; N, 11.54%.
Diethyl 2-(2-Cyanoallyl)-2-dimethylaminomalonate (3n):
IR (neat): 2984, 2906, 2839, 2795, 2224, 1756, 1728, 1620, 1465,
1448, 1391, 1367, 1303, 1235, 1209, 1094, 1064, 1041, 953, 859
cmꢂ1
.
1H NMR (400 MHz, CDCl3): ꢁ 1.31 (t, J ¼ 7:1 Hz, 6H),
2.43 (s, 6H), 2.97 (d, J ¼ 1:2 Hz, 2H), 4.27 (q, J ¼ 7:1 Hz, 4H),
5.90 (d, J ¼ 0:7 Hz, 1H), 6.00 (s, 1H). 13C NMR (100 MHz,